TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 25264565

Group type: EXPERIMENTAL
Intervention: Flupirtine IR (100 mg)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Flupirtine MR (400 mg once daily for 8 days)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Flupirtine IR
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Flupirtine MR
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Flupirtine
Number of subjects: 36
Study: 24252510

Group type: EXPERIMENTAL
Intervention: Referral to a weight management service with follow-up
Number of subjects: 1824

Group type: COMPARATOR
Intervention: Advice to lose weight on medical grounds
Number of subjects: 1824
Study: 21353585

Group type: EXPERIMENTAL
Intervention: Warm-blood cardioplegia supplemented with 16 mmol l⁻¹ Mg²⁺
Number of subjects: 691

Group type: COMPARATOR
Intervention: Warm-blood cardioplegia supplemented with 5 mmol l⁻¹ Mg²⁺
Number of subjects: 691
Study: 19596563

Group type: EXPERIMENTAL
Intervention: Aerosol provocation system (APS) using a single concentration of 16mg/mL methacholine (APS-SC)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Standard dosimeter method (SDM)
Number of subjects: 52
Study: 18035733

Group type: EXPERIMENTAL
Intervention: High stimulating rate ABR in MV
Number of subjects: 124

Group type: COMPARATOR
Intervention: High stimulating rate ABR in PCIV
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Cerebral MRI in MV
Number of subjects: 124

Group type: COMPARATOR
Intervention: Cerebral MRI in PCIV
Number of subjects: 124

Group type: COMPARATOR
Intervention: Abnormal blood pressure in PCIV
Number of subjects: 124

Group type: COMPARATOR
Intervention: Abnormal blood fat/pathoglycemia in PCIV
Number of subjects: 124

Group type: COMPARATOR
Intervention: Abnormal cervical vascular ultrasound in PCIV
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Motion sickness in MV
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Motion sensitivity in MV
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Photophobia/phonophobia in MV
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Abnormal ocular motion function in MV
Number of subjects: 124
Study: 15271108

Group type: EXPERIMENTAL
Intervention: Provider experience taking care of large numbers of elderly patients
Number of subjects: 800

Group type: EXPERIMENTAL
Intervention: Provider having a certificate of added qualifications in geriatrics
Number of subjects: 800

Group type: EXPERIMENTAL
Intervention: Practice style embodying traditional geriatric principles of care (prescribing no high-risk medications)
Number of subjects: 800

Group type: EXPERIMENTAL
Intervention: Practice style embodying traditional geriatric principles of care (managing geriatric syndromes)
Number of subjects: 800

Group type: EXPERIMENTAL
Intervention: Practice style embodying traditional geriatric principles of care (team care approach)
Number of subjects: 800
Study: 11405513

Group type: EXPERIMENTAL
Intervention: Formoterol 12 microg b.i.d. for 10-14 days
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Hydrocortisone 200 mg intravenously prior to salbutamol
Number of subjects: 10
Study: 8656156

Group type: EXPERIMENTAL
Intervention: Health decisions
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Money decisions
Number of subjects: 3
Study: 1295808

Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) co-treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 6707409

Group type: EXPERIMENTAL
Intervention: Physician/geriatric nurse practitioner/social worker home care team
Number of subjects: 33

Group type: COMPARATOR
Intervention: Usual nursing and other home care services (Control)
Number of subjects: 33
Study: 31597083

Group type: EXPERIMENTAL
Intervention: XC8 (10 mg)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: XC8 (50 mg)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: XC8 (200 mg)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: XC8 (all doses)
Number of subjects: 32
Study: 30293349

Group type: EXPERIMENTAL
Intervention: Intracytoplasmic sperm injection (ICSI) for MMAF patients
Number of subjects: 15

Group type: COMPARATOR
Intervention: Intracytoplasmic sperm injection (ICSI) for OA patients
Number of subjects: 15
Study: 24480721

Group type: EXPERIMENTAL
Intervention: Revised invitation letter
Number of subjects: 13551

Group type: COMPARATOR
Intervention: Original invitation letter
Number of subjects: 13551
Study: 22093076

Group type: EXPERIMENTAL
Intervention: Moderately rough implants (TiUnite)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Minimally rough implants (turned)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Partially edentulous patients
Number of subjects: 18

Group type: COMPARATOR
Intervention: Fully edentulous patients
Number of subjects: 18
Study: 21048171

Group type: EXPERIMENTAL
Intervention: Plantar fascia-specific stretching (Group I, n = 54)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Radial shock-wave therapy (Group II, n = 48)
Number of subjects: 102
Study: 17514344

Group type: EXPERIMENTAL
Intervention: 12 weeks of naltrexone
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: 24 weeks of naltrexone
Number of subjects: 146

Group type: COMPARATOR
Intervention: 12 weeks of naltrexone followed by 12 weeks of placebo
Number of subjects: 146
Study: 15720582

Group type: EXPERIMENTAL
Intervention: Correction-instructed group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Noninstructed group
Number of subjects: 0
Study: 12142185

Group type: EXPERIMENTAL
Intervention: Fibrin sealant (Beriplast P)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 52
Study: 10445774

Group type: EXPERIMENTAL
Intervention: 0.2% ropivacaine
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: 1% lidocaine
Number of subjects: 65
Study: 7768380

Group type: EXPERIMENTAL
Intervention: Octreotide (300 micrograms three times a day)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Octreotide
Number of subjects: 129
Study: 1645641

Group type: EXPERIMENTAL
Intervention: Cryotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Untreated eyes (Control)
Number of subjects: 0
Study: 7326866

Group type: EXPERIMENTAL
Intervention: Dexamethasone acetate at 2 of 3 mg/day for 9 or 13 weeks
Number of subjects: 14
Study: 31185971

Group type: EXPERIMENTAL
Intervention: Immediate-feedback
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Delayed-feedback
Number of subjects: 94

Group type: COMPARATOR
Intervention: Control
Number of subjects: 94
Study: 29068862

Group type: EXPERIMENTAL
Intervention: Polyphenol blend (PPB)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Placebo
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control
Number of subjects: 40
Study: 25648223

Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle exercise (Training group)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no pelvic floor muscle exercise)
Number of subjects: 60
Study: 24969283

Group type: EXPERIMENTAL
Intervention: 800 mg of rifaximin twice a day for 12 weeks
Number of subjects: 168

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: 800 mg of rifaximin
Number of subjects: 168
Study: 22000821

Group type: EXPERIMENTAL
Intervention: SMS reminder (n=342)
Number of subjects: 679

Group type: COMPARATOR
Intervention: No reminder (n=337)
Number of subjects: 679

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 679
Study: 19297236

Group type: EXPERIMENTAL
Intervention: Contact lenses offered before spectacle dispensing (test group)
Number of subjects: 91

Group type: COMPARATOR
Intervention: No contact lenses offered (control group)
Number of subjects: 91
Study: 17502725

Group type: EXPERIMENTAL
Intervention: Immediate PAIG injections (weeks 0 and 6)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Delayed PAIG injections (weeks 12 and 18)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Both immediate and delayed PAIG injections
Number of subjects: 31
Study: 15039688

Group type: EXPERIMENTAL
Intervention: Recalibrated Pediatric Risk of Admission (PRISA) score
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Recalibrated PRISA score
Number of subjects: 0
Study: 11795993

Group type: EXPERIMENTAL
Intervention: Laterally wedged insoles
Number of subjects: 156

Group type: COMPARATOR
Intervention: Neutrally wedged insoles (Control)
Number of subjects: 156
Study: 9932756

Group type: EXPERIMENTAL
Intervention: Patient-controlled sedation using propofol (10 mg/ml) and alfentanil (25 microg/ml)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Intravenous diazemuls (10-20 mg) and pethidine (50 mg)
Number of subjects: 66
Study: 7804031

Group type: EXPERIMENTAL
Intervention: Selenium concentration in children with cancer
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Glutathione peroxidase activity in children with cancer
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Selenium concentration in 3-7 year-old children with cancer
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Glutathione peroxidase activity in 3-7 year-old children with cancer
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Selenium concentration and glutathione peroxidase activity before and during treatment with cytostatics
Number of subjects: 205
Study: 3369334

Group type: EXPERIMENTAL
Intervention: Physical activity program
Number of subjects: 42

Group type: COMPARATOR
Intervention: Smoking habit change information
Number of subjects: 42

Group type: COMPARATOR
Intervention: Contact control
Number of subjects: 42
Study: 31999315

Group type: EXPERIMENTAL
Intervention: Learning and Coping (LC) in cardiac rehabilitation
Number of subjects: 825

Group type: COMPARATOR
Intervention: Standard cardiac rehabilitation (CR)
Number of subjects: 825
Study: 31981129

Group type: EXPERIMENTAL
Intervention: Culturally adapted Persian version of the Brace Questionnaire (P-BrQ)
Number of subjects: 51
Study: 28593360

Group type: EXPERIMENTAL
Intervention: Distance-delivered intervention (12-session cognitive behavioural informed handbook with telephone-based coaching support)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Distance-delivered intervention
Number of subjects: 62

Group type: COMPARATOR
Intervention: Standard community care (control)
Number of subjects: 62
Study: 26141665

Group type: EXPERIMENTAL
Intervention: In-pain group (n=18)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (n=22)
Number of subjects: 40
Study: 22584554

Group type: EXPERIMENTAL
Intervention: 2.1% sodium bicarbonate
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 1.05% sodium bicarbonate
Number of subjects: 18

Group type: COMPARATOR
Intervention: 0.9% normal saline
Number of subjects: 18
Study: 19796714

Group type: EXPERIMENTAL
Intervention: Open pro‐peritoneal repair
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Lichtenstein tension‐free mesh repair
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Transabdominal pro‐peritoneal (TAPP) repair
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Laparoscopic totally extraperitoneal (TEP) hernia repair
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Laparoscopic operations (TEP and TAPP)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Open repairs (control group)
Number of subjects: 100
Study: 17352869

Group type: EXPERIMENTAL
Intervention: Ruyiping
Number of subjects: 80

Group type: COMPARATOR
Intervention: Runing II
Number of subjects: 80
Study: 15871132

Group type: EXPERIMENTAL
Intervention: CX3CR1 I/I249 genotype
Number of subjects: 1055

Group type: COMPARATOR
Intervention: V249-T280 haplotype
Number of subjects: 1055
Study: 12116042

Group type: EXPERIMENTAL
Intervention: HBV vaccination during the first year of life
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HBV vaccination
Number of subjects: 0
Study: 10455474

Group type: EXPERIMENTAL
Intervention: Cycle ergometry at 50% of VO2 Peak
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Cycle ergometry at 75% of VO2 Peak
Number of subjects: 10
Study: 7887717

Group type: EXPERIMENTAL
Intervention: Short cannula (1.5 cm)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Long cannula (7.0 cm)
Number of subjects: 18
Study: 2231320

Group type: EXPERIMENTAL
Intervention: Immediate-release (IR) hydralazine thrice daily, daily doses of 75, 150, or 300 mg
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Extended-release (ER) hydralazine twice daily, daily doses of 75, 150, or 300 mg
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Extended-release (ER) hydralazine once daily, daily doses of 75, 150, or 300 mg
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Concomitant beta-blocker (BB) therapy
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Hydralazine treatment
Number of subjects: 181
Study: 112580

Group type: EXPERIMENTAL
Intervention: Chlorambucil maintenance
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Hydroxy-urea
Number of subjects: 109
Study: 31481362

Group type: EXPERIMENTAL
Intervention: Music therapy (MT) focusing on parental singing tailored to infant responses during NICU and/or postdischarge 6-month period
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Music therapy (MT)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 250
Study: 29947285

Group type: EXPERIMENTAL
Intervention: Ginger aromatherapy (inhalation of essential oil of ginger)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo (water)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control (Johnson's baby shampoo)
Number of subjects: 49
Study: 27816672

Group type: EXPERIMENTAL
Intervention: THS 2.2 (80 participants)
Number of subjects: 160

Group type: COMPARATOR
Intervention: CC (41 participants)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: SA (39 participants)
Number of subjects: 160

Group type: COMPARATOR
Intervention: THS 2.2 and CC (80 and 41 participants respectively)
Number of subjects: 160
Study: 24268387

Group type: EXPERIMENTAL
Intervention: omega-3 (1 g, 3 times daily)
Number of subjects: 50

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 50
Study: 22902139

Group type: EXPERIMENTAL
Intervention: Instrument-assisted spinal manipulative therapy (SMT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham manipulation procedure
Number of subjects: 30
Study: 20230454

Group type: EXPERIMENTAL
Intervention: 240 mg lidocaine in 125 mL of saline once a week for 4 weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: 25 mg amitriptyline
Number of subjects: 30
Study: 18942422

Group type: COMPARATOR
Intervention: New Russian oral ribavirin-containing agents
Number of subjects: 0
Study: 15675903

Group type: EXPERIMENTAL
Intervention: 90 seconds of CPR before defibrillation
Number of subjects: 256

Group type: COMPARATOR
Intervention: Immediate defibrillation
Number of subjects: 256
Study: 12352271

Group type: EXPERIMENTAL
Intervention: Nortriptyline
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 66
Study: 10329069

Group type: EXPERIMENTAL
Intervention: End-point committee evaluation of events
Number of subjects: 1209

Group type: EXPERIMENTAL
Intervention: End-point committee evaluation
Number of subjects: 1209

Group type: EXPERIMENTAL
Intervention: End-point committee judgements
Number of subjects: 1209
Study: 7559165

Group type: EXPERIMENTAL
Intervention: Two-filter model for frequency discrimination
Number of subjects: 3
Study: 2082489

Group type: EXPERIMENTAL
Intervention: Aspirin (330 mg) and dipyridamole (75 mg) t.i.d.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 7436817

Group type: EXPERIMENTAL
Intervention: Sinemet 20/100 (20 mg of carbidopa to 100 mg of levodopa)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Sinemet 10/100 (10 mg of carbidopa to 100 mg of levodopa)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Levodopa alone (100 mg)
Number of subjects: 29
Study: 31192423

Group type: EXPERIMENTAL
Intervention: Multimodal occupational specific treatment for exhaustion disorder
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Reflective peer support group sessions
Number of subjects: 0
Study: 28129020

Group type: EXPERIMENTAL
Intervention: Brinzolamide/Brimonidine Fixed Combination (BBFC) 1%/0.2% 3 times daily
Number of subjects: 60

Group type: COMPARATOR
Intervention: Timolol maleate 0.5% twice daily
Number of subjects: 60
Study: 25905534

Group type: EXPERIMENTAL
Intervention: Hot glutamate solution (48°C)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Cold glutamate solution (3°C)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Isotonic saline (neutral solution at 36°C)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Cold solutions
Number of subjects: 16
Study: 22941095

Group type: EXPERIMENTAL
Intervention: Neuromuscular exercise and counseling program for 6 months
Number of subjects: 1409

Group type: COMPARATOR
Intervention: Control group (signal, mortar)
Number of subjects: 1409
Study: 21343835

Group type: EXPERIMENTAL
Intervention: Low-dose ZENPEP (7 × 5000 lipase units per day)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: High-dose ZENPEP (7 × 20,000 lipase units per day)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: High-dose ZENPEP (7 × 20,000 lipase units per day) in patients with baseline CFA < 90% (n = 33)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Both doses of ZENPEP
Number of subjects: 72
Study: 19462726

Group type: EXPERIMENTAL
Intervention: Posterior Tibial Nerve electrical stimulation (n=21)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Sham group (n=16)
Number of subjects: 37
Study: 18611265

Group type: EXPERIMENTAL
Intervention: Multivariable model including four kallikrein forms (total, free, and intact PSA, and human kallikrein 2 (hK2))
Number of subjects: 740

Group type: EXPERIMENTAL
Intervention: Threshold for biopsy set at 20% risk of prostate cancer
Number of subjects: 740
Study: 15708868

Group type: EXPERIMENTAL
Intervention: Clonidine 150 microg (Cl-150)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clonidine 300 microg (Cl-300)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (Cl-0)
Number of subjects: 0

Group type: COMPARATOR
Intervention: ZEEP (zero end-expiratory pressure)
Number of subjects: 0
Study: 12231079

Group type: EXPERIMENTAL
Intervention: DCA with stent (DCA-stent)
Number of subjects: 117

Group type: COMPARATOR
Intervention: DCA only
Number of subjects: 117
Study: 10223454

Group type: EXPERIMENTAL
Intervention: Implantation of pre‐coincubated autologous adrenal medulla (AM) and intercostal nerve in the caudate nucleus.
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control group (nonsurgically treated patients).
Number of subjects: 8
Study: 7633545

Group type: EXPERIMENTAL
Intervention: Computer-generated telephone reminder calls
Number of subjects: 517

Group type: COMPARATOR
Intervention: No reminder calls (Control)
Number of subjects: 517

Group type: EXPERIMENTAL
Intervention: Computer-generated telephone reminder calls (Immunization program)
Number of subjects: 517

Group type: EXPERIMENTAL
Intervention: Computer-generated telephone reminder calls (Well-child program)
Number of subjects: 517

Group type: EXPERIMENTAL
Intervention: Computer-generated telephone reminder calls (Women, infant, and children program)
Number of subjects: 517

Group type: EXPERIMENTAL
Intervention: Computer-generated telephone reminder calls (Family-planning program)
Number of subjects: 517
Study: 2568774

Group type: EXPERIMENTAL
Intervention: Iopromide
Number of subjects: 40

Group type: COMPARATOR
Intervention: Iopamidol
Number of subjects: 40
Study: 594788

Group type: EXPERIMENTAL
Intervention: Methyclothiazide 10 mg daily
Number of subjects: 120

Group type: COMPARATOR
Intervention: Methyclothiazide 5 mg daily
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 29739243

Group type: EXPERIMENTAL
Intervention: Suture closure
Number of subjects: 746

Group type: COMPARATOR
Intervention: Staples
Number of subjects: 746
Study: 27476326

Group type: EXPERIMENTAL
Intervention: 5 weeks of training cessation
Number of subjects: 10
Study: 25846053

Group type: EXPERIMENTAL
Intervention: Balance-training program provided by qualified care workers (QCWs) for 6 months
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Balance-training program provided by qualified care workers (QCWs)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (no balance training)
Number of subjects: 45
Study: 23398703

Group type: EXPERIMENTAL
Intervention: Visual feedback system to alert operators of critical movements and to alert other workers in close proximity to the equipment.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Visual feedback system
Number of subjects: 0
Study: 21309619

Group type: EXPERIMENTAL
Intervention: Combined psycho- and pharmacotherapy for patients with co-morbid personality disorders (PDs)
Number of subjects: 562

Group type: COMPARATOR
Intervention: Combined psycho- and pharmacotherapy for patients with no personality disorders (PDs)
Number of subjects: 562
Study: 19167418

Group type: EXPERIMENTAL
Intervention: Heterozygous women
Number of subjects: 0

Group type: COMPARATOR
Intervention: Age-matched controls
Number of subjects: 0
Study: 16499796

Group type: EXPERIMENTAL
Intervention: 0.75% hyperbaric bupivacaine 1.5 ml with 0.25 ml fentanyl (12.5 microg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: 0.75% hyperbaric bupivacaine 1.5 ml with 0.25 ml normal saline
Number of subjects: 60
Study: 14679137

Group type: EXPERIMENTAL
Intervention: Temozolomide 200 mg/m2/day
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Temozolomide 250 mg/m2/day
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Temozolomide 300 mg/m2/day
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Temozolomide 350 mg/m2/day
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Temozolomide 300 mg/m2/day recommended dose
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Temozolomide (dose-dense regimen)
Number of subjects: 70
Study: 11704117

Group type: EXPERIMENTAL
Intervention: Ibuprofen (800 mg, three times per day for 10 days)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 9337922

Group type: EXPERIMENTAL
Intervention: Adjuvant radiotherapy
Number of subjects: 0
Study: 8197841

Group type: EXPERIMENTAL
Intervention: Gamma nail
Number of subjects: 378

Group type: COMPARATOR
Intervention: Hip Compression Screw (HCS)
Number of subjects: 378